Four investors are financing the further growth of i3 Membrane GmbH. High-tech venture capital investor HTGF from Bonn, Germany, and three private investors are together investing a 7 figure sum in the further development and market launch of new separation technology for biological molecul ... more
New Filter Technology – Uses Inert Gas to Bore Holes in High-Quality Steel
Two early-stage venture capital investors are joining the i3 Membrane GmbH startup in August 2014. High-Tech Gründerfonds (HTGF) of Bonn and Innovationsstarter Fonds of Hamburg are investing in development and marketing of a novel filter technology. The new high-tech membrane is made of high-quality steel and is more stable and more flexible than conventional filters, also more environmentally-compatible because only inert gas and electrical power are needed for its manufacture. The process was developed jointly with the Helmholtz-Zentrum Dresden-Rossendorf (HZDR) and its development is being sponsored by the Deutsche Bundesstiftung Umwelt (Federal German Environment Foundation).
“Our manufacturing process starts by accelerating large numbers of electrically-charged atoms of an inert gas and implanting them in high-quality steel foil. The tiny bubbles resulting from accumulation of these atoms in the foil lead to formation of larger pores”, explains Stephan Brinke-Seiferth, CEO of i3 Membrane GmbH, the company that, together with Prof. Andreas Kolitsch of the research center HZDR, had the idea of manufacturing this type of membrane back in 2012.
The newly-developed steel membrane is both durable and flexible. The project is supported by a grant of EUR 250,000 from the Deutsche Bundesstiftung Umwelt (Federal German Environment Foundation), because it eliminates the need for toxic chemicals. Initial product launch, currently planned for June 2015, will focus on preparation of samples for analysis of trace substances. This field of application will later be widened to include other uses in biotechnology and also in the field of water purification.
The global market for filter membranes, currently worth around 15 billion US dollars, is growing at a rate of around 10 percent per annum. Something like half of these sales go to the medical and pharmaceutical sectors, where plastic membranes developed back in the 1960s still dominate the market. i3 Membrane GmbH plans to target its products as an attractive alternative to plastic membranes, especially in highly sensitive applications.
“The new production process is intelligent and, at the same time, simple; we are convinced of its high promise and are looking forward to giving the company’s experienced team our support in building up a strong market position,” enthuses HTGF’s Investment Manager Ron Winkler.
Equally enthusiastic is Dörte Bunge of Innovationsstarter Fonds Hamburg: “We regard i3’s new process as extremely innovative and are confident that our investment presents an opportunity to create a new generation of membranes based on this technology.”
“i3 Membrane GmbH was founded in April 2013 with support from the Helmholtz Association. Its mission is to bring this newly-developed platform technology to market as quickly as possible. “Another contributory factor to this result has been the excellent technology transfer provided by the Helmholtz Center in Dresden,” adds Stephan Brinke-Seiferth.
Scientists at the Helmholtz-Zentrum Dresden-Rossendorf (HZDR), working with colleagues from the USA and Germany, have developed a new optical detector from graphene which reacts very rapidly to incident light of all different wavelengths and even works at room temperature. It is the first t ... more
Scientists at the Helmholtz-Zentrum Dresden-Rossendorf (HZDR) have studied the dynamics of electrons from the "wonder material" graphene in a magnetic field for the first time. This led to the discovery of a seemingly paradoxical phenomenon in the material. Its understanding could make a ne ... more
Medical diagnostics is searching for substances capable of documenting early on whether a serious disease is developing or what its course will be. In many cases, the treacherous molecules are present only in trace amounts – which is why extremely sensitive methods of detection are urgently ... more
Aignostics, a spin-off from Charité – Universitätsmedizin Berlin, developing novel digital pathology solutions with “Explainable AI” for pharmaceutical research and diagnostics, today announced the closing of an oversubscribed €14m Series A financing round. Wellington Partners led the round ... more
C-mo Medical Solutions is an award-winning start-up that is unravelling the potential of assessing cough towards improved diagnosis, treatment courses and disease management. The company has now raised 4.1€Mn in a seed round led by Boehringer Ingelheim Venture Fund. This investment will all ... more
Qnami announced today the closing of a 4.0M CHF (4.4M USD) Series A financing round led by Venture Capital funds Runa Capital and SIT Capital, further supported by Seed Round investors Quantonation, Verve Ventures, ZKB Start-up Finance and the High-Tech Gründerfonds. The funds will support ... more
- 1Can the AI driving ChatGPT help to detect early signs of Alzheimer's disease?
- 2Simple nasal swab can provide early warning of emerging viruses
- 3Holes in T cells
- 4Molecular archeology: 1200-year-old DNA sequences from Madagascar lead to the discovery of an extinct tortoise
- 5Diagnosing cancer in minutes
- 6Bruker Announces Acquisition of ACQUIFER Imaging GmbH
- 7How old is your brain, really?
- 8Sartorius with clear double-digit growth in fiscal 2022
- 9The architecture of shattered genomes
- 10A mobile breakthrough for water environment monitoring